Demirci, U. Et Al. 2016. Are RHOA CSNK1A1 DVL2 FZD8 and LRP5 New Gene Biomarkers in the Conversion from Intestinal Metaplasia to Gastric Cancer. ESMO 18th World Congress on Gastrointestinal Cancer, 29 June-2 July 2016, Barcelona, Spain .

Demirci, U., ÖRENAY BOYACIOĞLU, S., KASAP, E., Bilgiç, F., Gerçeker, E., Yıldırım, H., ... Baykan, A.(2016). Are RHOA CSNK1A1 DVL2 FZD8 and LRP5 New Gene Biomarkers in the Conversion from Intestinal Metaplasia to Gastric Cancer . ESMO 18th World Congress on Gastrointestinal Cancer, 29 June-2 July 2016, Barcelona, Spain

Demirci, Ufuk Et Al. "Are RHOA CSNK1A1 DVL2 FZD8 and LRP5 New Gene Biomarkers in the Conversion from Intestinal Metaplasia to Gastric Cancer," ESMO 18th World Congress on Gastrointestinal Cancer, 29 June-2 July 2016, Barcelona, Spain, 2016

Demirci, Ufuk Et Al. "Are RHOA CSNK1A1 DVL2 FZD8 and LRP5 New Gene Biomarkers in the Conversion from Intestinal Metaplasia to Gastric Cancer." ESMO 18th World Congress on Gastrointestinal Cancer, 29 June-2 July 2016, Barcelona, Spain , 2016

Demirci, U. Et Al. (2016) . "Are RHOA CSNK1A1 DVL2 FZD8 and LRP5 New Gene Biomarkers in the Conversion from Intestinal Metaplasia to Gastric Cancer." ESMO 18th World Congress on Gastrointestinal Cancer, 29 June-2 July 2016, Barcelona, Spain .

@conferencepaper{conferencepaper, author={Ufuk Demirci Et Al. }, title={Are RHOA CSNK1A1 DVL2 FZD8 and LRP5 New Gene Biomarkers in the Conversion from Intestinal Metaplasia to Gastric Cancer}, congress name={ESMO 18th World Congress on Gastrointestinal Cancer, 29 June-2 July 2016, Barcelona, Spain}, city={}, country={}, year={2016}}